MRI with manganese for takotsubo cardiomyopathy
Treatments studied
Part of Heart & circulation clinical trials.
This study uses a special MRI with a contrast agent called manganese to look at how the heart works in people with takotsubo cardiomyopathy (broken heart syndrome). It may help doctors understand why this condition happens and how to treat it better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You have been diagnosed with takotsubo cardiomyopathy (broken heart syndrome).
- You are able to have an MRI scan (no metal implants, no severe claustrophobia).
- You do not have severe kidney disease (this will be checked with a blood test).
- You are not pregnant, and you do not have severe asthma, type 1 diabetes, or low blood pressure that would make the study medications unsafe.
- You are not taking digoxin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI to learn more about Takotsubo syndrome (a temporary heart condition often triggered by stress). If you have been diagnosed with Takotsubo and have had certain heart tests, you may be able to join.
This study looks at Takotsubo (also called stress cardiomyopathy) and heart problems caused by sepsis using specialized heart imaging (including PET). The goal is to better understand what triggers these conditions and how the heart is affected, which may improve diagnosis and care.
This trial tests whether starting a beta-blocker (a heart medication that slows the heartbeat and lowers blood pressure) soon after Takotsubo syndrome diagnosis helps prevent complications. You may qualify if you were just diagnosed and have no other serious heart conditions.
This study uses a special MRI scan with a natural contrast agent (manganese) to look at how well the heart muscle works in people with heart failure who still have normal pumping strength. The goal is to learn more about why this type of heart failure happens.
This trial tests an optimized medication approach for people diagnosed with Takotsubo (“broken heart”) syndrome. It may help clinicians find a safer and more effective treatment plan after this heart condition.
This trial aims to understand the chemical and physical changes in the heart's blood vessels during Takotsubo syndrome, a temporary heart condition often triggered by stress. It may help doctors better diagnose and treat this condition.
Hear when a new Takotsubo Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.